Literature DB >> 17198393

Mapping the interaction of cofilin with subdomain 2 on actin.

Sabrina A Benchaar1, Yongming Xie, Martin Phillips, Rachel R Ogorzalek Loo, Vitold E Galkin, Albina Orlova, Mario Thevis, Andras Muhlrad, Steven C Almo, Joseph A Loo, Edward H Egelman, Emil Reisler.   

Abstract

Cofilin, a member of the actin-depolymerizing factor (ADF)/cofilin family of proteins, is a key regulator of actin dynamics. Cofilin binds to monomer (G-) and filamentous (F-) actin, severs the filaments, and increases their turnover rate. Electron microscopy studies suggested cofilin interactions with subdomains 2 and 1/3 on adjacent actin protomers in F-actin. To probe for the presence of a cryptic cofilin binding site in subdomain 2 in G-actin, we used transglutaminase-mediated cross-linking, which targets Gln41 in subdomain 2. The cross-linking proceeded with up to 85% efficiency with skeletal alpha-actin and WT yeast actin, yielding a single product corresponding to a 1:1 actin-cofilin complex but was strongly inhibited in Q41C yeast actin (in which Q41 was substituted with cysteine). LC-MS/MS analysis of the proteolytic fragments of this complex mapped the cross-linking to Gln41 on actin and Gly1 on recombinant yeast cofilin. The actin-cofilin (AC) heterodimer was purified on FPLC for analytical ultracentrifugation and electron microscopy analysis. Sedimentation equilibrium and velocity runs revealed oligomers of AC in G-actin buffer. In the presence of excess cofilin, the covalent AC heterodimer bound a second cofilin, forming a 2:1 cofilin/actin complex, as revealed by sedimentation results. Under polymerizing conditions the cross-linked AC formed mostly short filaments, which according to image reconstruction were similar to uncross-linked actin-cofilin filaments. Although a majority of the cross-linking occurs at Gln41, a small fraction of the AC cross-linked complex forms in the Q41C yeast actin mutant. This secondary cross-linking site was sequenced by MALDI-MS/MS as linking Gln360 in actin to Lys98 on cofilin. Overall, these results demonstrate that the region around Gln41 (subdomain 2) is involved in a weak binding of cofilin to G-actin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198393     DOI: 10.1021/bi0610754

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

2.  Cofilin-induced changes in F-actin detected via cross-linking with benzophenone-4-maleimide.

Authors:  Christine K Chen; Sabrina A Benchaar; Mai Phan; Elena E Grintsevich; Rachel R Ogorzalek Loo; Joseph A Loo; Emil Reisler
Journal:  Biochemistry       Date:  2013-07-31       Impact factor: 3.162

3.  Role of intermonomer ionic bridges in the stabilization of the actin filament.

Authors:  Ema Stokasimov; Melissa McKane; Peter A Rubenstein
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

4.  Mapping the cofilin binding site on yeast G-actin by chemical cross-linking.

Authors:  Elena E Grintsevich; Sabrina A Benchaar; Dora Warshaviak; Pinmanee Boontheung; Frédéric Halgand; Julian P Whitelegge; Kym F Faull; Rachel R Ogorzalek Loo; David Sept; Joseph A Loo; Emil Reisler
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

5.  Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.

Authors:  Lise Munsie; Nicholas Caron; Randy Singh Atwal; Ian Marsden; Edward J Wild; James R Bamburg; Sarah J Tabrizi; Ray Truant
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

6.  Interactions of histatin-3 and histatin-5 with actin.

Authors:  Edna Blotnick; Asaf Sol; Gilad Bachrach; Andras Muhlrad
Journal:  BMC Biochem       Date:  2017-03-06       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.